SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
KARACHI,Pakistan,Feb. 25,2025--Kerry,a global leader in taste and nutrition,has partnered with Far Eastern Impex (FEI) to open the first international production operation for flavourings in Pakistan
- Annual General Meeting on Mar. 26th,agendas include director appointment SEOUL,South Korea,Feb. 25,2025-- KT&G Corporation ("KT&G" or the "Company") (KRX:033780) held a
XUZHOU,China,Feb. 25,2025--The 3rd XCMG & FinDreams Super Battery Day was successfully held at the XCMG International Conference Center,Xuzhou,focused on cutting-edge technologies and explored new
SK bioscience\'s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand,with interim results expected by 2026
